Left field takeover offer based on yesterday's extraordinary secondary endpoint result.
Not in isolation but when viewed with all previous other data (MSB and other stemcell research) illustrating efficacy and safety profiles.
Who wouldn't be rushing in on those results for an asymmetric paradigm shift upside. Then bidding war.
Ann: Trading halt, page-63
-
- There are more pages in this discussion • 734 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $2.372M | 2.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 65931 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 9535 | 2 |
View Market Depth
| Last trade - 13.23pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |